跳至主要内容
临床试验/NCT04044443
NCT04044443进行中(未招募)不适用

Post Market Registry of the IMPEDE and IMPEDE-FX Embolization Plugs

Shape Memory Medical, Inc.10 个研究点 分布在 2 个国家目标入组 108 人开始时间: 2019年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
108
试验地点
10
主要终点
Safety - Rate of freedom from serious adverse events

研究概览

简要总结

EMBO-PMS is a prospective, multicentre, registry study of the IMPEDE and IMPEDE-FX Embolization Plug Systems

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study participant is ≥18 years of age
  • Study participant is considered a candidate for arterial or venous embolization of the peripheral vasculature

排除标准

  • Study participant has an inability to provide written informed consent
  • Study participant/treatment outside of the approved study device labeling, instructions for use (IFU)
  • Study participant is a prisoner or member of other vulnerable population

结局指标

主要结局

Safety - Rate of freedom from serious adverse events

时间窗: 30 days

Rate of freedom from serious adverse events related to the study devices and/or procedure, per review and adjudication by medical monitor

Efficacy - Rate of technical success (embolization of target vessel)

时间窗: Immediately after the intervention

Technical success, defined as embolization of the target area after deployment of the study device

次要结局

  • Efficacy - Rate of treated vessel occlusion(90 days)
  • Safety - Rate of freedom from serious adverse events(90 days)
  • Efficacy - Rate of recurrence of clinical symptoms, based on original complaint(90 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验